AllianceBernstein’s Fortress Biotech FBIO Stock Holding History

AllianceBernstein’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,013	Closed	-$41K	–	3305
2022 Q1	$41K	Sell	2,013 -327	-14%	-$8.95K	﹤0.01%	3188
2021 Q4	$88K	Hold	2,340	–	–	﹤0.01%	3209
2021 Q3	$113K	Hold	2,340	–	–	﹤0.01%	3172
2021 Q2	$125K	Buy	2,340 +587	+33%	+$35.4K	﹤0.01%	3219
2021 Q1	$93K	Hold	1,753	–	–	﹤0.01%	3165
2020 Q4	$83K	Hold	1,753	–	–	﹤0.01%	3121
2020 Q3	$106K	Hold	1,753	–	–	﹤0.01%	3070
2020 Q2	$70K	Buy	+1,753	New	+$65.1K	﹤0.01%	3136
2019 Q1	–	Sell	-767	Closed	-$10K	–	3123
2018 Q4	$10K	Hold	767	–	–	﹤0.01%	3094
2018 Q3	$18K	Hold	767	–	–	﹤0.01%	3135
2018 Q2	$34K	Buy	+767	New	+$43.2K	﹤0.01%	3100
2013 Q4	–	Sell	-92,969	Closed	-$9.79M	–	3455
2013 Q3	$9.79M	Buy	92,969 +92,320	+14,225%	+$11.3M	0.01%	822
2013 Q2	$84K	Buy	+649	New	+$95.7K	﹤0.01%	2959

Other funds holding FBIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SAM

Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

AllianceBernstein's FBIO Position: Q2 2022 in Review

AllianceBernstein sold out of Fortress Biotech (FBIO) in Q2 2022, closing a stake of 2,013 shares — an estimated $41K sold.

AllianceBernstein first reported a position in FBIO in Q2 2013 and held it in 13 quarters. The position peaked at $9.79M in Q3 2013. 66 funds tracked by Wall St. Rank hold FBIO as of Q2 2022.

AllianceBernstein reported no remaining Fortress Biotech position as of Q2 2022 after selling out during the quarter.
AllianceBernstein sold 2,013 Fortress Biotech shares in Q2 2022, an estimated $41K.
AllianceBernstein first reported a position in Fortress Biotech in Q2 2013 and held it in 13 quarters.
AllianceBernstein's Fortress Biotech position peaked at $9.79M in Q3 2013.
66 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.